TITLE

Validation of a model to diagnosis cirrhosis in patients with chronic hepatitis C

AUTHOR(S)
Siddiqui, Ali; Fazili, Javid; Mesiya, Sikander
PUB. DATE
September 2003
SOURCE
American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS94
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
An abstract of the article "Validation of a Model to Diagnosis Cirrhosis in Patients With Chronic Hepatitis C," by Ali Siddiqui, Javid Fazili and Sikander Mesiya is presented.
ACCESSION #
66954306

 

Related Articles

  • The Hepatitis C Patient: Functional Assessment and Effective Botanical Remedies. Calvino, Nicholas // Townsend Letter for Doctors & Patients;Dec2002, Issue 233, p74 

    Focuses on the functional assessment and botanical remedies of patient with hepatitis C. Symptoms of the disease; Causes of chronic liver disease; Percentage of hepatitis C patients with cirrhosis.

  • A giant spider nevus in a patient of hepatitis C-related liver cirrhosis: A rare presentation. Sood, Ajit; Gupta, Rahul; Midha, Vandana // International Journal of Applied & Basic Medical Research;Sep-Dec2015, Vol. 5 Issue 3, p206 

    Spider nevi are benign vascular lesions mostly seen in patients with decompensated liver cirrhosis. Mostly, these are seen in the superior vena cava distribution and are small with pinhead size central vessel. Giant spider nevus is rarely seen and hence this report.

  • A PROSPECTIVE STUDY TO ASSESS RESPONSE TO 3 MONTHS OF COMBINATION TREATMENT IN CHRONIC HEPATITIS C INFECTION. Kumar, N.; Teague, B.; Paine, P.; Mukerjee, S.; Higham, A.; Brown, C.; Stewart, A.; Askew, T.; Davies, A.; Polland, M.; Keating, J. // Gut;Apr2003 Supplement 1, Vol. 52, pA107 

    Current recommendations, including NICE guidance, suggest treating genotype I hepatitis C with combination treatment for 12 months and genotype II/III for 6 months. However, this prolonged course of treatment puts enormous strain on budgets, thereby limiting its use and the length of this...

  • The relationship of Acute Transfusion-Associated Hepatitis to the Development of Cirrhosis in the Presence of Alcohol Abuse. Harris, D. Robert; Gonin, Rene; Alter, Harvey J.; Wright, Elizabeth C; Buskell, Zelma J.; Hollinger, F. Blaine; Seeff, Leonard B. // Annals of Internal Medicine;01/16/2001, Vol. 134 Issue 2, p120 

    Examines the relationship between acute transfusion-associated hepatitis and cirrhosis in the presence of alcohol abuse in the United States. Estimation of cirrhosis risk through logistic regression; Absolute risk for cirrhosis.

  • Rare complication of variceal embolization: a novel case. Oza, Veeral M.; Levine, Edward; Kirkpatrick III, Robert // Journal of Interventional Gastroenterology;7/ 1/2012, Vol. 3 Issue 3, p113 

    A letter to the editor is presented about the case of a 61-year-old female with a history of cirrhosis secondary to Hepatitis C who developed an embolization coil eroding thru a duodenal varix.

  • Retraction.  // Acta Medica Marisiensis;Jun2014, Vol. 60 Issue 3, p134 

    A correction to the article "Relationship Between Genotypes of Hepatitis C Virus and the Progression to Cirrhosis in Chronic Hepatitis C Patients" that was published in the 2014 issue is presented.

  • Estimation of Copper and Iron Burden in Biological Samples of Various Stages of Hepatitis C and Liver Cirrhosis Patients. Arain, Salma; Kazi, Tasneem; Afridi, Hassan; Talpur, Farah; Mughal, Moina; Shah, Faheem; Arain, Sadaf; Panhwar, Abdul // Biological Trace Element Research;Aug2014, Vol. 160 Issue 2, p197 

    There is accumulative evidence that the metabolism of iron (Fe) and copper (Cu) is altered in human due to infections, indicating that both elements have roles in pathogenesis and progress of viral diseases. In the present study, the correlation of Cu and Fe was evaluate in biological samples...

  • HCC risk persists 8 years after HCV eradication.  // Infectious Disease News;Jun2013, Vol. 26 Issue 6, p36 

    The article discusses the results of a study which concluded that patients with hepatitis C-induced liver cirrhosis have a long-term risk for hepatocellular carcinoma of up to 8 years after sustained virological response to antiviral therapy.

  • HEPATITIS C CIRRHOSIS--NOT NECESSARILY A TERMINAL DISEASE. Saeian, Kia; Reddy, K. Rajender; Johnson, David // American Journal of Gastroenterology;Aug1998, Vol. 93 Issue 8, p1386 

    Provides information on a study that evaluated the morbidity and survival of patients with compensated, histologically proven cirrhosis from hepatitis C virus infection. Methodology of the study; Results and discussion of the study.

  • The Practice of Percutaneous Liver Biopsy in a Gastrohepatology Day Hospital: A Retrospective Study on 835 Biopsies. Alda Olivero; Marco Lagget; Rinaldo Pellicano; Antonina Smedile; Mario Rizzetto // Digestive Diseases & Sciences;Oct2007, Vol. 52 Issue 10, p2576 

    Abstract  The evolving role of liver biopsy has induced the formulation of several guidelines on its appropriateness. However, the great divergence among hepatologists is still unresolved. We report the 4-year activity of a day hospital of gastrohepatology in northern Italy....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics